NYMX
Nymox Pharmaceutical Corp
NYMX
NYMX
Delisted
NYMX was delisted on the 6th of July, 2023.
45 hedge funds and large institutions have $5.19M invested in Nymox Pharmaceutical Corp in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less call options, than puts
Call options by funds: $27K | Put options by funds: $40K
Holders
45
Holding in Top 10
–
Calls
$27K
Puts
$40K
Top Buyers
| 1 | +$216K | |
| 2 | +$198K | |
| 3 | +$189K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$147K |
| 5 |
HAG
HighPoint Advisor Group
Downers Grove,
Illinois
|
+$102K |
Top Sellers
| 1 | -$244K | |
| 2 | -$110K | |
| 3 | -$64K | |
| 4 |
WS
Wedbush Securities
Los Angeles,
California
|
-$44.3K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$42.7K |